Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

Saved in:
Bibliographic Details
Main Authors: Schuler, Esther (Author) , Nolte, Florian (Author)
Format: Article (Journal) Editorial
Language:English
Published: 26 January 2016
In: Leukemia
Year: 2016, Volume: 30, Issue: 7, Pages: 1580-1582
ISSN:1476-5551
DOI:10.1038/leu.2015.340
Online Access:Verlag, Volltext: https://doi.org/10.1038/leu.2015.340
Verlag, Volltext: https://www.nature.com/articles/leu2015340
Get full text
Author Notes:E. Schuler, A. Giagounidis, D. Haase, K. Shirneshan, G. Büsche, U. Platzbecker, F. Nolte, K. Götze, R.F. Schlenk, A. Ganser, A. Letsch, F. Braulke, M. Lübbert, G. Bug, P. Schafhausen, U. Bacher, N. Gattermann, M. Wulfert, R. Haas and U. Germing
Description
Item Description:Gesehen am 10.07.2019
Physical Description:Online Resource
ISSN:1476-5551
DOI:10.1038/leu.2015.340